Resultats de la cerca - Ernest T. Hawk

Refinar resultats
  1. 1
    Cancer Prevention: From 1727 to Milestones of the Past 100 Years

    Cancer Prevention: From 1727 to Milestones of the Past 100 Years per Scott M. Lippman, Ernest T. Hawk

    Publicat 2009
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Colorectal cancer chemoprevention—an overview of the science1 1This article was prepared in our capacity as employees of the U.S. Federal Government.

    Colorectal cancer chemoprevention—an overview of the science1 1This article was prepared in our capacity as employees of the U.S. Federal Government. per Ernest T. Hawk, Asad Umar, Jaye L. Viner

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Chemoprevention in hereditary colorectal cancer syndromes

    Chemoprevention in hereditary colorectal cancer syndromes per Ernest T. Hawk, R Lubet, Paul J. Limburg

    Publicat 1999
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Cancer Chemoprevention: Successes and Failures

    Cancer Chemoprevention: Successes and Failures per Sherri Patterson, Karen Colbert Maresso, Ernest T. Hawk

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  5. 5
    Mind the Gap: Precision Oncology and Its Potential to Widen Disparities

    Mind the Gap: Precision Oncology and Its Potential to Widen Disparities per Ryan Huey, Ernest T. Hawk, Anaeze C. Offodile

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  6. 6
    Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention

    Coxibs and Other Nonsteroidal Anti-Inflammatory Drugs in Animal Models of Cancer Chemoprevention per Susan M. Fischer, Ernest T. Hawk, Ronald A. Lubet

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  7. 7
    COX-2 in Cancer--A Player That's Defining the Rules

    COX-2 in Cancer--A Player That's Defining the Rules per Ernest T. Hawk, Jaye L. Viner, Andrew J. Dannenberg, Raymond N. DuBois

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Carta
    Afegir a favorits
    Guardat en:
  8. 8
    Molecular cancer prevention: Current status and future directions

    Molecular cancer prevention: Current status and future directions per Karen Colbert Maresso, Kenneth Y. Tsai, Powel H. Brown, Éva Szabó, Scott M. Lippman, Ernest T. Hawk

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes

    GWAS-identified colorectal cancer susceptibility loci associated with clinical outcomes per Jingyao Dai, Jian Gu, Maosheng Huang, Cathy Eng, Scott Kopetz, Lee M. Ellis, Ernest T. Hawk, Xifeng Wu

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Genome-wide methylation analysis shows similar patterns in Barrett’s esophagus and esophageal adenocarcinoma

    Genome-wide methylation analysis shows similar patterns in Barrett’s esophagus and esophageal adenocarcinoma per Enping Xu, Jian Gu, Ernest T. Hawk, Kenneth K. Wang, Maode Lai, Maosheng Huang, Jaffer A. Ajani, Xifeng Wu

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Platelet “first responders” in wound response, cancer, and metastasis

    Platelet “first responders” in wound response, cancer, and metastasis per David G. Menter, Scott Kopetz, Ernest T. Hawk, Anil K. Sood, Jonathan M. Loree, Paolo Gresele, Kenneth V. Honn

    Publicat 2017
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  12. 12
    Molecular mechanisms of the preventable causes of cancer in the United States

    Molecular mechanisms of the preventable causes of cancer in the United States per Erica A. Golemis, Paul Scheet, Tim N. Beck, Eward M. Scolnick, David J. Hunter, Ernest T. Hawk, Nancy Hopkins

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  13. 13
    Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic

    Use of non-steroidal anti-inflammatory drugs in US adults: changes over time and by demographic per Jennifer S. Davis, Hwa Young Lee, Jihye Kim, Shailesh Advani, Ho-Lan Peng, Emilyn Banfield, Ernest T. Hawk, Shine Chang, Alexis C. Wood

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    MicroRNA Expression Signatures during Malignant Progression from Barrett's Esophagus to Esophageal Adenocarcinoma

    MicroRNA Expression Signatures during Malignant Progression from Barrett's Esophagus to Esophageal Adenocarcinoma per Xifeng Wu, Jaffer A. Ajani, Jian Gu, David W. Chang, Weiqi Tan, Michelle A.T. Hildebrandt, Maosheng Huang, Kenneth K. Wang, Ernest T. Hawk

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    A Randomized Phase IIb Trial of Anethole Dithiolethione in Smokers with Bronchial Dysplasia

    A Randomized Phase IIb Trial of Anethole Dithiolethione in Smokers with Bronchial Dysplasia per Stephen Lam, Calum MacAulay, Jean C. Le Riche, Yulia Dyachkova, Andy Coldman, Martial Guillaud, Ernest T. Hawk, Marie Odile Christen, Adi F. Gazdar

    Publicat 2002
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors

    Clinical factors associated with adherence to aerobic and resistance physical activity guidelines among cancer prevention patients and survivors per Adriana M. Coletta, Guillermo Márquez, Parijatham S. Thomas, Whittney S. Thoman, Therese B. Bevers, Abenaa M. Brewster, Ernest T. Hawk, Karen Basen‐Engquist, Susan C. Gilchrist

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis

    Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis per Jian Gu, Jaffer A. Ajani, Ernest T. Hawk, Yuanqing Ye, Jeffrey H. Lee, Manoop S. Bhutani, Wayne L. Hofstetter, Stephen G. Swisher, Kenneth K. Wang, Xifeng Wu

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention

    Beyond COX-1: the effects of aspirin on platelet biology and potential mechanisms of chemoprevention per Argentina Ornelas, Niki M. Zacharias, David G. Menter, Jennifer S. Davis, Lenard M. Lichtenberger, David H. Hawke, Ernest T. Hawk, Eduardo Vilar, Pratip K. Bhattacharya, Steven W. Millward

    Publicat 2017
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  19. 19
    Prevention by aspirin and its combination with α-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon

    Prevention by aspirin and its combination with α-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon per Hong Li, Herman A.J. Schut, Philip B. Conran, Paula M. Kramer, Ronald A. Lubet, Vernon E. Steele, Ernest E. Hawk, Gary J. Kelloff, Michael A. Pereira

    Publicat 1999
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention

    Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention per Scott D. Solomon, John J.V. McMurray, Marc A. Pfeffer, Janet Wittes, Robert Fowler, Peter Finn, William F. Anderson, Ann G. Zauber, Ernest T. Hawk, Monica M. Bertagnolli

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: